Last updated: May 29, 2026
LIVTENCITY suppliers: Who manufactures, supplies, and provides contract manufacturing for maribavir (VICARx) in the US and EU?
LIVTENCITY (maribavir) supply is dominated by one primary branded-drug commercial supply stream. Independent “supplier” layers fall into three buckets: (1) active pharmaceutical ingredient (API) and key intermediates, (2) finished-dose manufacturing and packaging, and (3) secondary logistics and distribution.
No complete, verified supplier map for LIVTENCITY (API makers, fill-finish/packagers, and contract manufacturing organizations by site) is available in the provided source context, so a full, citation-backed supplier roster cannot be produced.
Which companies supply LIVTENCITY (maribavir) to wholesalers and pharmacies?
Featured answer: Branded supply originates from the label holder’s authorized distribution network in the US, with finished product manufactured at approved commercial sites and released by the manufacturer of record.
What are the LIVTENCITY API and intermediate suppliers for maribavir?
Featured answer: Maribavir API supply is provided by one or more qualified API manufacturers and intermediate producers feeding approved commercial drug substance routes.
Which CDMOs manufacture and package LIVTENCITY finished tablets?
Featured answer: Finished-dose manufacturing and packaging are performed by the company’s approved commercial manufacturing and packaging sites (often CDMOs or in-house units), with each site referenced in regulatory filings and release documentation.
What is the Orange Book status of LIVTENCITY, and does it affect supplier access?
Featured answer: Orange Book listings govern US generic and biosimilar applicants and are not a direct public supplier index.
When does LIVTENCITY lose exclusivity, and how does that change supplier competition?
Featured answer: Exclusivity and patent/market exclusivity timelines determine entry timing for generics and the volume/availability pressure that typically triggers broader supplier qualification in finished-dose supply chains.
How many manufacturing sites make LIVTENCITY, and what are the typical redundancy and surge-capacity patterns?
Featured answer: Branded supply chains typically use one main commercial site with additional qualified backup sites, but the exact number of LIVTENCITY manufacturing and packaging sites must be pulled from site-level regulatory references to be accurate.
What regulatory filings list LIVTENCITY manufacturers and distributors?
Featured answer: NDA labeling, FDA database records, and EU product dossiers identify the manufacturer of record, packaging sites, and marketing authorization holder, but those specifics are not included in the provided context.
What contract manufacturing risks exist for LIVTENCITY supply continuity?
Featured answer: Supply continuity risk is driven by single-site manufacturing exposure, raw-material bottlenecks for API, and batch-release capacity. A site-resolved risk view requires manufacturer-of-record and site identifiers that are not provided here.
How does LIVTENCITY supply compare with other maribavir-related products?
Featured answer: Comparative supply risk and supplier breadth usually track whether comparable products use multi-site manufacturing versus single-site dominance and whether API is captive versus contracted, but that cannot be established without site-resolved supplier data for LIVTENCITY.
Key Takeaways
- LIVTENCITY (maribavir) supply is organized through a primary manufacturer-of-record and an approved distribution network, with additional layers for API/intermediates and packaging.
- A verified, site-level supplier roster (API makers, CDMOs, packagers, and distributors) is not available in the provided information context, so a complete supplier list cannot be produced without citations to regulator-accessible records and label/manufacturing documentation.
FAQs
- Is maribavir’s API sourced globally or from one qualified supplier?
- Which finished-dose manufacturing sites produce LIVTENCITY tablets for the US market?
- Do LIVTENCITY packaging and labeling suppliers differ by region (US vs EU)?
- How do FDA inspection outcomes at manufacturing sites affect LIVTENCITY supply?
- What supplier changes usually occur ahead of generic launch for maribavir?
References
- (No sources provided in the prompt context.)
